Hualan Biological EngineeringInc (002007) — Financial Flexibility Index
Hualan Biological EngineeringInc (002007) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥355.60 Million (operating CF CN¥319.46 Million minus capex CN¥36.14 Million) represents 0% of total liabilities (CN¥3.02 Billion). Check cash flow reinvestment rate of Hualan Biological EngineeringInc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hualan Biological EngineeringInc Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for Hualan Biological EngineeringInc across 22 annual periods. For the full cash flow conversion analysis, see 002007 operating cash flow.
Annual Financial Flexibility Index for Hualan Biological EngineeringInc (2003–2024)
Year-by-year free cash flow to debt coverage for Hualan Biological EngineeringInc. Explore 002007 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.53x | CN¥1.32 Billion | CN¥1.06 Billion | CN¥2.46 Billion | ▼ -31.7% |
| 2023 | 0.78x | CN¥2.10 Billion | CN¥1.35 Billion | CN¥2.68 Billion | ▲ +46.4% |
| 2022 | 0.53x | CN¥1.35 Billion | CN¥957.31 Million | CN¥2.53 Billion | ▼ -41.1% |
| 2021 | 0.91x | CN¥2.24 Billion | CN¥1.43 Billion | CN¥2.47 Billion | ▼ -9.7% |
| 2020 | 1.00x | CN¥1.95 Billion | CN¥1.33 Billion | CN¥1.94 Billion | ▼ -57.1% |
| 2019 | 2.34x | CN¥1.64 Billion | CN¥1.36 Billion | CN¥699.26 Million | ▲ +14.2% |
| 2018 | 2.05x | CN¥1.48 Billion | CN¥1.29 Billion | CN¥720.47 Million | ▲ +170.2% |
| 2017 | 0.76x | CN¥285.95 Million | CN¥177.42 Million | CN¥377.24 Million | ▼ -70.4% |
| 2016 | 2.56x | CN¥550.60 Million | CN¥329.94 Million | CN¥215.05 Million | ▼ -54.9% |
| 2015 | 5.67x | CN¥777.96 Million | CN¥548.62 Million | CN¥137.11 Million | ▲ +19.2% |
| 2014 | 4.76x | CN¥636.36 Million | CN¥497.15 Million | CN¥133.70 Million | ▲ +108.3% |
| 2013 | 2.29x | CN¥759.91 Million | CN¥510.70 Million | CN¥332.55 Million | ▼ -53.1% |
| 2012 | 4.87x | CN¥641.85 Million | CN¥494.69 Million | CN¥131.84 Million | ▲ +56.3% |
| 2011 | 3.11x | CN¥479.52 Million | CN¥335.93 Million | CN¥153.99 Million | ▼ -30.2% |
| 2010 | 4.46x | CN¥759.20 Million | CN¥609.53 Million | CN¥170.06 Million | ▼ -9.8% |
| 2009 | 4.95x | CN¥770.16 Million | CN¥607.73 Million | CN¥155.67 Million | ▲ +101.8% |
| 2008 | 2.45x | CN¥288.07 Million | CN¥161.18 Million | CN¥117.50 Million | ▲ +80.0% |
| 2007 | 1.36x | CN¥392.93 Million | CN¥179.02 Million | CN¥288.51 Million | ▼ -11.1% |
| 2006 | 1.53x | CN¥348.73 Million | CN¥131.43 Million | CN¥227.67 Million | ▲ +45.7% |
| 2005 | 1.05x | CN¥156.83 Million | CN¥98.24 Million | CN¥149.20 Million | ▲ +247.0% |
| 2004 | 0.30x | CN¥43.48 Million | CN¥21.48 Million | CN¥143.53 Million | ▲ +83.2% |
| 2003 | 0.17x | CN¥36.17 Million | CN¥3.35 Million | CN¥218.79 Million | — |